CTCBIO Inc. 060590.KQ Stock
8240 KRW
{{ price }}
-1.794258%
{{change_pct}}%
COUNTRY
South Korea
Exchange
KOSDAQ
Market Cap
197.01B KRW
LOW - HIGH [24H]
8150
-
8290 KRW
VOLUME [24H]
23.45K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
CTCBIO Inc. Price Chart
CTCBIO Inc. 060590.KQ Financial and Trading Overview
| CTCBIO Inc. stock price | 8240 KRW |
| Previous Close | 10200 KRW |
| Open | 10210 KRW |
| Bid | 10130 KRW x 0 |
| Ask | 10130 KRW x 0 |
| Day's Range | 10050 - 10500 KRW |
| 52 Week Range | 5930 - 12780 KRW |
| Volume | 151.85K KRW |
| Avg. Volume | 507.76K KRW |
| Market Cap | 192.86B KRW |
| Beta (5Y Monthly) | 0.96094 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
060590.KQ Valuation Measures
| Enterprise Value | 255.19B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.1148145 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.475 |
| Enterprise Value/EBITDA | 12.667 |
Trading Information
CTCBIO Inc. Stock Price History
| Beta (5Y Monthly) | 0.96094 |
| 52-Week Change | 12.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12780 KRW |
| 52 Week Low | 5930 KRW |
| 50-Day Moving Average | 10491.8 KRW |
| 200-Day Moving Average | 8296.55 KRW |
060590.KQ Share Statistics
| Avg. Volume (3 month) | 507.76K KRW |
| Avg. Daily Volume (10-Days) | 233.35K KRW |
| Shares Outstanding | 19.04M |
| Float | 16.21M |
| Short Ratio | N/A |
| % Held by Insiders | 18.92% |
| % Held by Institutions | 0.56% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.1:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 5.82% |
| Operating Margin (ttm) | 7.87% |
| Gross Margin | 31.36% |
| EBITDA Margin | 11.64% |
Management Effectiveness
| Return on Assets (ttm) | 4.74% |
| Return on Equity (ttm) | 10.21% |
Income Statement
| Revenue (ttm) | 173B KRW |
| Revenue Per Share (ttm) | 7309.07 KRW |
| Quarterly Revenue Growth (yoy) | 17.59% |
| Gross Profit (ttm) | 33.09B KRW |
| EBITDA | 20.15B KRW |
| Net Income Avi to Common (ttm) | 10.07B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 22.29B KRW |
| Total Cash Per Share (mrq) | 932.41 KRW |
| Total Debt (mrq) | 39.75B KRW |
| Total Debt/Equity (mrq) | 37.33 KRW |
| Current Ratio (mrq) | 1.553 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 16.03B KRW |
| Levered Free Cash Flow (ttm) | 4.86B KRW |
Profile of CTCBIO Inc.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | Sambo Building |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.ctcbio.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 248 |
CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. It offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. The company was founded in 1995 and is headquartered in Seoul, South Korea.
Q&A For CTCBIO Inc. Stock
What is a current 060590.KQ stock price?
CTCBIO Inc. 060590.KQ stock price today per share is 8240 KRW.
How to purchase CTCBIO Inc. stock?
You can buy 060590.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CTCBIO Inc.?
The stock symbol or ticker of CTCBIO Inc. is 060590.KQ.
How many shares does CTCBIO Inc. have in circulation?
The max supply of CTCBIO Inc. shares is 23.91M.
What is CTCBIO Inc. Price to Earnings Ratio (PE Ratio)?
CTCBIO Inc. PE Ratio is now.
What was CTCBIO Inc. earnings per share over the trailing 12 months (TTM)?
CTCBIO Inc. EPS is 0 KRW over the trailing 12 months.